Evidence map›Paper›PMID 42422831›Full record

ArticleFrontiers in medicine2026

An XGBoost-based model for detecting undiagnosed type 2 diabetes using routine physical and lifestyle data from a multi-center Chinese population.

Hui Xiao, Qian Xi, Ping Zeng, Jinjuan Hao, Qinghua He, Xiaoxia Wang, Chi Zhang

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hui XiaoTianjin University, Tianjin, China.
Qian XiThe University of Hong Kong, Hong Kong, Hong Kong SAR, China.
Ping ZengDepartment of Basic Innovation Research, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Beijing Key Laboratory of Aging Mechanism and Intervention Research on Aging-Related Diseases, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Jinjuan HaoDepartment of Basic Innovation Research, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Beijing Key Laboratory of Aging Mechanism and Intervention Research on Aging-Related Diseases, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
Qinghua HeDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Xiaoxia WangDepartment of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Chi ZhangDepartment of Basic Innovation Research, Beijing Hospital, National Center for Gerontology, National Clinical Research Center for Gerontology, The Key Laboratory of Geriatrics of NHC, Beijing Key Laboratory of Aging Mechanism and Intervention Research on Aging-Related Diseases, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to develop and validate an interpretable machine learning model to identify individuals with undiagnosed type 2 diabetes (T2D) using data readily available from routine health checkups. Methods: In this retrospective study, we analyzed data from 12 tertiary hospitals in China. Following the application of inclusion and exclusion criteria, data from 11,382 individuals formed the training set for developing an XGBoost model, which was optimized using 5-fold cross-validation. An independent test set of 1,026 individuals from the same multi-center data source was used for internal validation. Model performance was primarily assessed using the area under the receiver operating characteristic curve (AUC). Results: The final model incorporated 12 predictors. Fasting blood glucose was the most influential predictor (50.6%), followed by creatinine (6.6%), triglyceride (5.6%), age (5.1%), and low-density lipoprotein (5.0%). On the independent test set, the model achieved an AUC of 77.2% (95%CI: 70.3%-84.1%). Conclusion: The XGBoost model demonstrated moderate predictive performance for T2D risk using routine checkup data. This approach shows potential for integration into clinical practice as an assistive screening tool, enabling automated risk profiling during standard health examinations. By flagging high-risk individuals, it can support clinicians in decision-making regarding further diagnostic testing. Future work should focus on external validation and prospective implementation studies.

Indexed as

health checkupmachine learningrisk predictiontype 2 diabetesXGBoost

Identifiers

PMID42422831
PMCPMC13341501

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.